Skip to main content
. 2021 Mar 20;70(10):2991–3000. doi: 10.1007/s00262-021-02910-x

Table 1.

Patient demographics

Patient demographics
Patients enrolled/treated 17
Median age in years (range) 57 (25–76)

Median number of prior therapies (range)

Prior immunotherapy

3 (0–4)*

2

Diagnoses
Ovarian (incl. high-grade serous ovarian cancer—10; low-grade serous ovarian cancer—2; clear cell ovarian cancer—2) 14
Soft tissue sarcoma (incl. uterine leiomyosarcoma, malignant solitary fibrous tumor) 2
Colorectal cancer 1

*One patient enrolled with 5 prior systemic therapies, one line was on an experimental trial